Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs Seagate Technology Holdings PLC (STX) Price & Performance

Cassava Sciences IncTrade
Seagate Technology Holdings PLCTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Seagate Technology Holdings PLC — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Seagate Technology Holdings PLC trades at $863 (market cap $185.97B). The key difference: Seagate Technology Holdings PLC is far larger — about 3894.7× Cassava Sciences Inc's market cap, and Seagate Technology Holdings PLC pays a 0.36% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.

FLNASTX
Market Cap
$47.75M$185.97B
Sector
HealthTechnology
52-Week High
$4.64$1.09K
52-Week Low
$0.87$154.43
Enterprise Value
-$34.93M$188.12B
Dividend Yield
0.36%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $0.9973, up 0.23% with a bearish technical signal despite recent earnings beats. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though cash burn improved from -$33M to -$30M projected for 2026. Analyst consensus is strongly bullish with 8 buy ratings versus 4 hold ratings.

The outlook remains challenging due to persistent losses and negative cash flow, but analyst optimism and continued progress in TSC-related epilepsy therapies provide potential catalysts. Key risks include execution challenges in clinical development and the company's ability to secure additional funding.

Seagate Technology Holdings PLC

Seagate Technology (STX) trades at $800.74, down 1.48% today, with a bearish technical signal but strong recent earnings beats driven by AI storage demand. The company reported Q2 2026 EPS of $5.71, beating expectations of $5.10, with revenue growth and margin expansion supported by its HAMR technology and data center contracts. However, high valuation ratios (P/E 59.03, P/S 15.41) and negative shareholder equity pose fundamental concerns.

The outlook is mixed: AI-driven demand and analyst bullishness (54.91% buy ratings) support upside to the $1,130 consensus target, but elevated valuation, legal settlements, and competitive pressures in the storage market present significant risks. Cash flow volatility and debt levels require monitoring for sustained growth.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA

About Seagate Technology Holdings PLC

Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital

Read more on STX